Del.icio.us
Google
Yahoo MyWeb
Facebook
REVA Medical Overview
Founded in 1998, REVA Medical is dedicated to developing interventional medical devices that leverage the Company's novel stent designs and biomaterials to improve the treatment of vascular disease.
The Company's flagship product is a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product...More»
Founded in 1998, REVA Medical is dedicated to developing interventional medical devices that leverage the Company's novel stent designs and biomaterials to improve the treatment of vascular disease.
The Company's flagship product is a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product promises to revolutionize the treatment of coronary artery disease.
The Company is also developing an ultra-thin balloon expandable nickel titanium stent and radiopaque, bioresorbable embolic beads for the treatment of uterine fibroids and other applications.
REVA Medical has a broad strategic relationship with Boston Scientific Corporation, a worldwide developer and marketer of interventional medical devices. The Company is also certified to the ISO 13485:2003 standard.«Less
Key People
Management
- Robert Schultz, President
- Katrina Thompson, VP Finance & Administration
- Joan Zeltinger, VP Scientific Affairs
- Jeff Anderson, VP Regulatory & Clinical Affairs
- Don Brandom, VP Biomaterials Product Development
- Eric Schmid, VP Engineering & Stent Development
- Cheryl Liberatore, Director of Corporate Development
Board of Directors
Funding
No funding information added yet. Add funding information.
Products
| Name: | Bioresorbable Coronary Stent |
| Product URL: | http://www.teamreva.com/tech_bioresorbable.html |
| Description: | Coronary artery disease is currently treated by the placement of a metal stent that serves as a permanent scaffold for the vessel. However, it is now generally believed that a stents purpose is fully served upon vessel healing. The REVA Bioresorbable Coronary Stent is designed to act as a temporary scaffold during the healing process. Once the vessel has healed, the stent is designed to resorb, leaving the patient free from a permanent implant. |
| Screenshots: |
|
Competitors
Profile
OpinionsRelated Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »
Similar Companies
View All Similar »Web Metrics
View All Web Metrics »
| Alexa Rank: | n/a |  |
n/a |
| Yahoo Search Results: | n/a | ||
News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
REVA Medical Looks To Australia For IPO
Aug 16, 2010 - 0 comments
REVA Medical on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...